IBM International Business Machines Options Ahead of Earnings
If you haven`t bought the dip on IBM:
Then analyzing the options chain and the chart patterns of IBM International Business Machines prior to the earnings report this week,
I would consider purchasing the 170usd strike price Puts with
an expiration date of 2024-5-17,
for a premium of approximately $2.29.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Then analyzing the options chain and the chart patterns of IBM International Business Machines prior to the earnings report this week,
I would consider purchasing the 170usd strike price Puts with
an expiration date of 2024-5-17,
for a premium of approximately $2.29.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade closed: target reached
IBM traded at $165.74 after earnings, and the Puts went up from $2.29 (when I wrote this article) to $5.60 at the close today (a lot higher intraday), for about 2.44X gain!
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.